Case study shows that site activation is a key driver in determining patient enrollment cycle time, which can be minimized by identifying the "sweet spot" of sites to deploy for a clinical trial.
Valerie Legagneur
Advertisement
Articles by Valerie Legagneur
Case study demonstrates that site activation is a key driver in determining patient enrollment cycle time.
Advertisement
Latest Updated Articles
Enrollment Cycle Times Can and Should Be OptimizedPublished: January 17th 2018 | Updated:
- Enrollment Cycle Times Can and Should Be Optimized
Published: January 17th 2018 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Future-Proofing Clinical Trial Supply Chains Against Tariff Risks
2
Eli Lilly’s Orforglipron Shows Superior Efficacy Across Multiple Phase III Trials in Type 2 Diabetes
3
Reframing the IND: From Tactical Requirement to Strategic Opportunity
4
Streamlining Trial Design to Accelerate Data Delivery and Investor Confidence
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
